MTOR Protein

MTOR Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MTOR Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>[mTOR](/proteins/mtor-protein) (Mechanistic Target of Rapamycin)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>MTOR</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P42345</td>
</tr>
<tr>
<td class="label">PDB ID</td>
<td>1NSG, 4J5V</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~289 kDa (2549 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytosol, Lysosomes</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>PI3K-related kinase family</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Rapamycin (Sirolimus)</td>
<td>Allosteric mTORC1 inhibitor</td>
</tr>
<tr>
<td class="label">Everolimus</td>
<td>mTORC1/2 inhibitor</td>
</tr>
<tr>
<td class="label">Torin 1</td>
<td>ATP-competitive inhibitor</td>
</tr>
<tr>
<td class="label">AZ5</td>
<td>ATPD805-competitive inhibitor</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/adh" style="color:#ef9a9a">ADH</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer-disease" style="color:#ef9a9a

MTOR Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MTOR Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>[mTOR](/proteins/mtor-protein) (Mechanistic Target of Rapamycin)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>MTOR</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P42345</td>
</tr>
<tr>
<td class="label">PDB ID</td>
<td>1NSG, 4J5V</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~289 kDa (2549 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytosol, Lysosomes</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>PI3K-related kinase family</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Rapamycin (Sirolimus)</td>
<td>Allosteric mTORC1 inhibitor</td>
</tr>
<tr>
<td class="label">Everolimus</td>
<td>mTORC1/2 inhibitor</td>
</tr>
<tr>
<td class="label">Torin 1</td>
<td>ATP-competitive inhibitor</td>
</tr>
<tr>
<td class="label">AZ5</td>
<td>ATPD805-competitive inhibitor</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/adh" style="color:#ef9a9a">ADH</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer-disease" style="color:#ef9a9a">ALZHEIMER DISEASE</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-51e7234f" style="color:#ce93d8" title="Score: 0.80">APOE-Dependent Autophagy Restoration...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">4198 edges</a></td>
</tr>
</table>

[Mtor](/mechanisms/mtor-signaling-pathway) Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

The MTOR protein (Mechanistic Target of Rapamycin) is a serine/threonine kinase that serves as a central regulator of cell growth, metabolism, and autophagy. It integrates nutritional, growth factor, and energy signals to control protein synthesis and autophagy. [mTOR](/entities/mtor) dysregulation is implicated in Alzheimer's disease, Parkinson's disease, and tuberous sclerosis.

Protein Information

Structure

mTOR is a large protein with multiple domains:

• HEAT repeats (N-terminal)
• FAT domain
• FRB domain (FKBP12-rapamycin binding)
• Kinase domain (C-terminal)
• FATC domain

Complexes

mTOR exists in two functionally distinct complexes:

mTORC1 (mTOR + Raptor)

• Nutrient sensing
• Protein synthesis regulation (S6K1, 4E-BP1)
• [Autophagy](/entities/autophagy) inhibition
• Cell growth

mTORC2 (mTOR + Rictor)

• Actin cytoskeleton
• Cell survival (Akt activation)
• Metabolic regulation

Role in Neurodegeneration

Alzheimer's Disease

• Autophagy Impairment: mTOR hyperactivation inhibits autophagy, leading to [Aβ](/proteins/amyloid-beta) and [tau](/proteins/tau) accumulation
• Synaptic Dysfunction: mTOR regulates synaptic plasticity
• Therapeutic: Rapamycin (mTOR inhibitor) shows promise in AD models

Parkinson's Disease

• [α-Synuclein](/proteins/alpha-synuclein) accumulation due to impaired autophagy
• mTOR dysregulation in PD substantia nigra
• Rapamycin protects dopaminergic [neurons](/entities/neurons)

Tuberous Sclerosis Complex

• TSC1/2 mutations cause mTOR hyperactivation
• mTOR inhibitors (everolimus, sirolimus) are approved

Therapeutic Targeting

Key Publications

[@saxton2022]: Lipton JO, et al. (2015). mTOR in brain function. Nat Rev Neurosci 16(1): 30-42.

[@liu2021]: Swiech L, et al. (2014). mTOR in neuronal plasticity. Neuropsychopharmacology 39(1): 54-62.

[@costamattioli2020]: Caccamo A, et al. (2010). Rapamycin in AD model. J Biol Chem 285(17): 13180-13188.

[@hoeffer2019]: Hoeffer CA, et al. (2010). mTOR and memory. Nat Rev Neurosci 11(2): 126-138.

Pathway & Interaction Diagram

Interactive diagram showing MTOR's key relationships in the SciDEX knowledge graph (15 connections shown).

See Also

• [MTOR Gene](/proteins/mtor-protein)
• [AMPK Protein](/proteins/ampk-protein)
• [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [UniProt: mTOR](https://www.uniprot.org/uniprot/P42345)
• [PDB: mTOR](https://www.ebi.ac.uk/pdbe/alpha/1NSG)
• [GeneCards: MTOR](https://www.genecards.org/cgi-bin/carddisp.pl?gene=MTOR)

Background

The study of Mtor Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Molecular Mechanisms

mTOR (mechanistic Target of Rapamycin) is a serine/threonine kinase that integrates cellular signals to regulate growth and metabolism:

• Complex formation: Exists in two complexes - mTORC1 (rapamycin-sensitive) and mTORC2 (rapamycin-insensitive)
• mTORC1: Contains mTOR, Raptor, mLST8; senses nutrients, energy, growth factors
• mTORC2: Contains mTOR, Rictor, mLST8; regulates cytoskeleton and cell survival
• Signaling: Phosphorylates S6K1, 4E-BP1, ULK1, TFEB

• Protein synthesis: Through S6K1 and 4E-BP1
• Autophagy: Inhibits autophagy through ULK1 and TFEB phosphorylation
• Metabolism: Activates glycolysis and lipid synthesis
• Cell growth: Controls cell size and proliferation

Role in Neurodegeneration

• Alzheimer's disease: mTOR hyperactivation impairs autophagy; contributes to Aβ and tau accumulation
• Parkinson's disease: mTOR dysregulation affects α-synuclein clearance
• ALS: mTOR signaling altered in motor neurons
• Therapeutic: Rapamycin and analogs (rapalogs) in clinical trials

Therapeutic Targeting

• Rapamycin/Sirolimus: Allosteric mTORC1 inhibitor
• AZD8055: ATP-competitive mTOR inhibitor
• Dual mTORC1/2 inhibitors: Torin 1, AZD8055
• mTOR + autophagy: Combinatorial approaches

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [APOE-Dependent Autophagy Restoration](/hypothesis/h-51e7234f) — <span style="color:#81c784;font-weight:600">0.73</span> · Target: MTOR